Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × tandutinib × Clear all

NCT00408902 2017-11-22

Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer

Phase 2 Completed

10 enrolled 6 charts

Carcinoma, Renal Cell